Aline Charabaty, MD
Johns Hopkins School of Medicine
Potomac, Maryland
Christina Ha, MD, FACG, AGAF
Mayo Clinic Scottsdale
Scottsdale, Arizona
David Rubin, MD, FACG
University of Chicago Medicine
Chicago, Illinois
Christina Ha, MD, FACG, AGAF
Mayo Clinic Scottsdale
Scottsdale, Arizona
David Rubin, MD, FACG
University of Chicago Medicine
Chicago, Illinois
During this session, participants will learn about risk stratification for Crohn's disease and ulcerative colitis patients, treatment goals and key factors to consider when determining first and subseuqent line therapies
Moderator: Aline Charabaty, MD – Johns Hopkins School of Medicine
Speaker: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
Speaker: David T. Rubin, MD, FACG – University of Chicago Medicine
Moderator: Aline Charabaty, MD – Johns Hopkins School of Medicine
Panelist: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
Panelist: David T. Rubin, MD, FACG – University of Chicago Medicine